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Dysregulation of the immune system is a fundamental dis-
ease mechanism, yet is incompletely understood. Human
genetics offers one approach to understand dysregulation
of the immune system in human diseases. Until recently, a
major bottleneck has been the identification of DNA var-
iants (alleles) that contribute to risk of disease. Through
international collaborations, many groups have employed
genome-wide mapping approach on thousands of samples
using common single nucleotide polymorphisms (SNPs).
These studies, termed genome-wide association studies
( G W A S ) ,h a v ed i s c o v e r e d> 1 5 0l o c it h a tc o n f e rr i s ko f
common autoimmune diseases such rheumatoid arthritis
(RA), type 1 diabetes (T1D), systemic lupus erythematosus
(SLE), celiac disease, and inflammatory bowel disease
(IBD). For most of these autoimmune diseases, these risk
alleles explain approximately 25% of disease burden,
whereas >50% of autoimmune disease risk is thought to be
genetic, indicating that additional risk alleles remain to be
discovered. In addition to finding new risk alleles, a next
critical step is to understand how these alleles disrupt nor-
mal immune function. In this way, the field of human
genetics hopes to gain insight into fundamental mechan-
isms that lead to autoimmunity, which in turn could help
guide the development of novel therapies.
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